National AIDS Update, San Francisco, March 23-26: Treatment, Science Coverage
This year's 11th National HIV/AIDS Update (see announcement in AIDS Treatment News #313) will focus more on treatment and new research than this conference did in previous years. Kevin Frost of the American Foundation for AIDS Research (AmFAR) noted some of the topics (not a complete list):
Immune-based therapy, Thursday afternoon, looking at Remune(tm), IL-2, GM-CSF, and other experimental treatments;
Strategies for treatment-experienced patients, including an overview of drug resistance, strategies for approaching resistance, and new compounds with different resistance profiles;
Early vs. late treatment, illuminating the debate about balancing side effects of treatment vs. possible immune damage from waiting, when we lack adequate tests to show what is happening immunologically;
Post-exposure prophylaxis (preventive treatment in case of accidental needlestick or sexual exposure);
Hepatitis C, and HIV, in incarcerated populations;
Medical marijuana;
Update from the Retroviruses conference in Chicago;
Public health and AIDS, with Joycelyn Elders, M.D., former U.S. Surgeon General;
National policy update, with Sandra Thurman, Director, White House Office of AIDS Policy.
For more information, see http://www.amfar.org/cgi-bin/iowa/nauc/index.html, or contact KREBS Convention Management Services, 415-920-7000, fax 415-920-7001.
